Abstract: Contrary to the widely-spread assumption that horses just have restricted cognitive capacities and are not very flexible in their behaviors, we showed that horses display innovative behavior and even make use of tools (Krueger 2015, Krueger et al. 2015). These findings derive from a database (http://innovative-behaviour.org/) the Equine behavior team managed in the past two years. Some horses did not only show single innovations, but several different innovations. The number of innovations per individual varied from 1 to 10. 20 % of all innovative horses in the database showed more than one innovation. These individuals can be called the ‘true innovators’. Moreover innovations were dependent on age. Young horses were more innovative than older ones, whereby horses at the age of five to nine years were the most innovative. When considering the housing system innovative horses in a single housing (inside box, outside box, paddock box) had a slight majority towards horses in group housing (open stable, active stable, pasture day and night). But given the fact that ratings on housing system frequencies state 95% of the horses to be kept in individual housing, innovations in individual housing are rare. Nevertheless, horses kept in inside boxes without a window, opened doors more often than all other horses. Aside from this effect, housing systems did not trigger the frequency of innovative behavior. Innovations for gaining freedom and innovations in general were widespread among horses with daily access to pasture and daily contact with conspecifics. Innovations for gaining food were not more likely to occur in horses that were fed little amounts of roughage. In conclusion, the housing of horses does not seem to be the primary catalyst for developing innovative behavior in horses. What makes a “true innovator” in horses, in addition to age, remains to be seen.

Abstract: Glucocorticoids or their metabolites can be measured in several body fluids or excreta, including plasma, saliva, urine and faeces. In recent years the measurement of glucocorticoid metabolites (GCMs) in faeces has gained increasing attention, because of its suitability for wild populations. In horses, however, the group-specific enzyme immunoassay described so far has a limited racticability due to its complex extraction procedure. Therefore, we tested the applicability of
other enzyme immunoassays for glucocorticoid metabolites. The present study clearly proved that an enzyme immunoassay (EIA) for 11-oxoetiocholanolone using 11-oxoetiocholanolone-17-CMO: BSA (3α,11-oxo-A EIA) as antigen showed high amounts of immunoreactive substances. Therefore it was possible to use just a small amount of the supernatant of a methanolic suspension of faeces. The results
correlated well with the already described method for measuring GCMs in horse faeces, i.e. analysing the samples with an EIA after a two step clean up procedure of the samples (Merl et al. 2000). In addition, the 3α,11-oxo-A EIA has the advantage of providing a bigger difference between baseline values and peak values after ACTH stimulation. The new assay increased the accuracy of the test,
lowered the expenses per sample, and storing samples at room temperature after collection was less critical than with other assays investigated in our study. This is a big advantage both in the field of wildlife management of equids and in the field of equestrian sports and it shows the importance of choosing an assay which is in good accordance with the metabolites excreted in a given species.